Patents by Inventor Huang-Chung Tseng

Huang-Chung Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190198145
    Abstract: An interactive precision health care system related to high blood sugar includes an examination module generating an examination report, a database and a processing module. The database stores the examination report, a characteristic information, and a health care information. The characteristic information has a first range. The processing module receives and compares the examination report with the characteristic information. When a pre-meal blood sugar level falls within the first range, the processing module generates a dietary supplement product list including a product information and a time schedule of taking medicine. The processing module controls a delivery module to proceed with delivery. The processing module controls a reminding module to send out a message of taking medicine to obtain a new examination report. The processing module modifies the dietary supplement product list.
    Type: Application
    Filed: January 12, 2018
    Publication date: June 27, 2019
    Inventors: TZUNG-SHIARN PAN, HUANG-CHUNG TSENG
  • Patent number: 9999645
    Abstract: A method of making longan seed extract is provided with choosing an extraction solvent; heating the extraction solvent to a first predetermined temperature; adding pulverized longan seed to the extraction solvent to prepare a solution; maintaining the solution at a second temperature for a predetermined period of time to obtain an extracted substance; filtering the extracted substance; and drying and cooling the filtered extracted substance to produce an extract.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: June 19, 2018
    Assignee: JOBEN BIO-MEDICAL CO., LTD.
    Inventors: Huang-Chung Tseng, Chien-Wei Hou
  • Patent number: 9308233
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: April 12, 2016
    Assignee: JOBEN BIO-MEDICAL CO., LTD.
    Inventors: Huang-Chung Tseng, Giao-Zhi Huang, Tung-An Chia
  • Patent number: 9259451
    Abstract: The present invention provides use of alcohol extract of longan seeds for manufacturing a drug for treating kidney tissue dysfunction. Preferably, an ethyl acetate sub-fraction of the alcohol extract of longan seeds has a better effect in treating kidney tissue dysfunction.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: February 16, 2016
    Assignee: JOBEN BIO-MEDICAL CO., LTD.
    Inventors: Huang-Chung Tseng, Yi-Ting Hsiao, You-Zhong Zhan, Chun-Yi Yen, Jian-Sheng Lin
  • Publication number: 20150147416
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Application
    Filed: February 3, 2015
    Publication date: May 28, 2015
    Inventors: HUANG-CHUNG TSENG, GIAO-ZHI HUANG, TUNG-AN CHIA
  • Patent number: 8986754
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: March 24, 2015
    Assignee: Joben Bio-Medical Co., Ltd.
    Inventors: Huang-Chung Tseng, Giao-Zhi Huang, Tung-An Chia
  • Publication number: 20150079205
    Abstract: A method of making longan seed extract is provided with choosing an extraction solvent; heating the extraction solvent to a first predetermined temperature; adding pulverized longan seed to the extraction solvent to prepare a solution; maintaining the solution at a second temperature for a predetermined period of time to obtain an extracted substance; filtering the extracted substance; and drying and cooling the filtered extracted substance to produce an extract.
    Type: Application
    Filed: July 9, 2014
    Publication date: March 19, 2015
    Inventors: Huang-Chung Tseng, Chien-Wei Hou
  • Publication number: 20150079204
    Abstract: A method of making longan seed extract is provided with choosing an extraction solvent; heating the extraction solvent to a first predetermined temperature; adding pulverized longan seed to the extraction solvent to prepare a solution; maintaining the solution at a second temperature for a predetermined period of time to obtain an extracted substance; filtering the extracted substance; and drying and cooling the filtered extracted substance to produce an extract.
    Type: Application
    Filed: July 9, 2014
    Publication date: March 19, 2015
    Inventors: Huang-Chung Tseng, Chien-Wei Hou
  • Publication number: 20150072032
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Application
    Filed: November 12, 2014
    Publication date: March 12, 2015
    Inventors: HUANG-CHUNG TSENG, GIAO-ZHI HUANG, TUNG-AN CHIA
  • Patent number: 8911800
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 16, 2014
    Assignee: Joben Bio-Medical Co., Ltd.
    Inventors: Huang-Chung Tseng, Giao-Zhi Huang, Tung-An Chia
  • Publication number: 20140178510
    Abstract: The present invention provides a composition comprising extract of adlay bran, wherein the adlay bran extract comprises C1 to C7 alcohol extract of adlay bran (A) and carbon dioxide supercritical fluid extract of adlay bran (B). Preferably, the extract of adlay bran has effects in treating a skin and/or subcutaneous tissue disease and in lowering interleukin (IL)-1?, interleukin-1?, interleukin-6, tumor necrosis factor (TNF)-?, interleukin-8, prostaglandin-2 (PGE2) and/or C-Reactive Protein (CRP).
    Type: Application
    Filed: March 15, 2013
    Publication date: June 26, 2014
    Inventors: Huang-Chung TSENG, Giao-Zhi HUANG, Tung-An CHIA
  • Publication number: 20140093597
    Abstract: The present invention provides use of alcohol extract of longan seeds for manufacturing a drug for treating kidney tissue dysfunction. Preferably, an ethyl acetate sub-fraction of the alcohol extract of longan seeds has a better effect in treating kidney tissue dysfunction.
    Type: Application
    Filed: March 18, 2013
    Publication date: April 3, 2014
    Applicant: JOBEN BIO-MEDICAL CO., LTD.
    Inventors: HUANG-CHUNG TSENG, YI-TING HSIAO, YOU-ZHONG ZHAN, CHUN-YI YEN, JIAN-SHENG LIN
  • Publication number: 20120177761
    Abstract: A method of making longan seed extract is provided with choosing an extraction solvent; heating the extraction solvent to a first predetermined temperature; adding pulverized longan seed to the extraction solvent to prepare a solution; maintaining the solution at a second temperature for a predetermined period of time to obtain an extracted substance; filtering the extracted substance; and drying and cooling the filtered extracted substance to produce an extract.
    Type: Application
    Filed: July 8, 2009
    Publication date: July 12, 2012
    Inventors: Chien-Wei Hou, Ying-Chung lee, Huang-Chung Tseng, Jer-Yi Liao, Giao-Zhi Huang, Chieh-Wei Huang, Chun-Lan Keng
  • Patent number: 5619063
    Abstract: The present invention is directed to an antifuse structure and fabrication process wherein the bottom oxide of the ONO antifuse material layer is grown over a small area of N- diffusion surrounded by an N+ diffusion area where the N- diffusion could be patterned as N- "islands" or as N- "stripes", or the like, with the active N- area controlled by the formation and drive-in of the N+ diffusion layer. In this way, the bottom oxide layer of the ONO antifuse material layer is thinner at its center (above the N- region) than at its edges because oxide grows slower on the less doped N- region at the center of the antifuse than at the more heavily doped N+ regions at the edges of the antifuse. Forcing the center of the antifuse material layer to be thinner causes the antifuse to preferentially break down at its center and away from its edges. The opening in the antifuse cell opening mask is wider than the width of the N- diffusion area so that both N- and N+ areas are exposed in the antifuse cell opening step.
    Type: Grant
    Filed: December 12, 1995
    Date of Patent: April 8, 1997
    Assignee: Actel Corporation
    Inventors: Wenn-Jei Chen, Huang-Chung Tseng